CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,644 | +342.8% | 6,917 | +305.5% | 0.00% | – |
| Q2 2023 | $4,436 | -59.7% | 1,706 | -70.9% | 0.00% | – |
| Q3 2022 | $11,000 | -38.9% | 5,859 | -2.4% | 0.00% | – |
| Q2 2022 | $18,000 | +5.9% | 6,000 | +31.6% | 0.00% | – |
| Q1 2022 | $17,000 | -32.0% | 4,558 | +109.3% | 0.00% | – |
| Q4 2021 | $25,000 | +257.1% | 2,178 | +448.6% | 0.00% | – |
| Q3 2021 | $7,000 | – | 397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,459,572 | $6,985,184 | 15.71% |
| BML Capital Management, LLC | 3,250,008 | $9,230,023 | 8.48% |
| Newtyn Management, LLC | 2,500,444 | $7,101,261 | 1.75% |
| VR Advisory Services Ltd | 1,072,968 | $3,047,229 | 1.08% |
| Anson Funds Management LP | 1,324,114 | $3,760,484 | 0.76% |
| Acuitas Investments, LLC | 329,164 | $934,826 | 0.55% |
| Aldebaran Capital, LLC | 143,739 | $408,219 | 0.42% |
| Bulldog Investors, LLP | 200,000 | $568,000 | 0.20% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 416,200 | $1,182,008 | 0.19% |
| Alta Fundamental Advisers LLC | 117,346 | $333,263 | 0.16% |